199 related articles for article (PubMed ID: 9861236)
1. Acute myelogenous leukemia with monosomy 7, inv(3) (q21q26), involving activated EVI 1 gene occurring after a complete remission of lymphoblastic lymphoma: a case report.
Igarashi T; Shimizu S; Morishita K; Ohtsu T; Itoh K; Minami H; Fujii H; Sasaki Y; Mukai K
Jpn J Clin Oncol; 1998 Nov; 28(11):688-95. PubMed ID: 9861236
[TBL] [Abstract][Full Text] [Related]
2. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
[TBL] [Abstract][Full Text] [Related]
3. Masked MLL gene rearrangement was disclosed in the clinical course and sequential development of chromosome abnormality in a patient with therapy related acute myelogenous leukemia.
Hashimoto S; Toba K; Izumi N; Sato N; Takahashi H; Ozawa T; Moriyama M; Aoki S; Furukawa T; Narita M; Takahashi M; Aizawa Y
Leuk Res; 2003 Mar; 27(3):285-90. PubMed ID: 12537982
[TBL] [Abstract][Full Text] [Related]
4. Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocations.
Russell M; List A; Greenberg P; Woodward S; Glinsmann B; Parganas E; Ihle J; Taetle R
Blood; 1994 Aug; 84(4):1243-8. PubMed ID: 8049440
[TBL] [Abstract][Full Text] [Related]
5. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript.
Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH
Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486
[TBL] [Abstract][Full Text] [Related]
6. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
[TBL] [Abstract][Full Text] [Related]
7. [Acute myeloid leukemia with monosomy 7 and inv(3)(q21q26.2) complicated with central diabetes insipidus].
Nanno S; Hagihara K; Sakabe M; Okamura H; Inaba A; Nagata Y; Nishimoto M; Koh H; Nakao Y; Nakane T; Nakamae H; Shimono T; Hino M
Rinsho Ketsueki; 2013 Apr; 54(4):397-402. PubMed ID: 23666224
[TBL] [Abstract][Full Text] [Related]
8. Evi-1 and MDS1-Evi-1 genes in pathogenesis of myelodysplastic syndromes and post-MDS acute myeloid leukemia.
Xu K; Wang L; Hao Y; Shao Z; Meng Q; Li K; Chao H; Tang K; Wang L
Chin Med J (Engl); 1999 Dec; 112(12):1112-8. PubMed ID: 11721451
[TBL] [Abstract][Full Text] [Related]
9. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
[TBL] [Abstract][Full Text] [Related]
10. Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26).
Suzukawa K; Parganas E; Gajjar A; Abe T; Takahashi S; Tani K; Asano S; Asou H; Kamada N; Yokota J
Blood; 1994 Oct; 84(8):2681-8. PubMed ID: 7919381
[TBL] [Abstract][Full Text] [Related]
11. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
[TBL] [Abstract][Full Text] [Related]
12. Central diabetes insipidus and inv(3)(q21q26) and monosomy 7 in acute myeloid leukemia.
Keung YK; Buss D; Powell BL; Pettenati M
Cancer Genet Cytogenet; 2002 Jul; 136(1):78-81. PubMed ID: 12165457
[TBL] [Abstract][Full Text] [Related]
13. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities.
Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R
J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia.
Brozek I; Babińska M; Kardaś I; Woźniak A; Balcerska A; Hellmann A; Limon J
J Appl Genet; 2003; 44(3):401-12. PubMed ID: 12923315
[TBL] [Abstract][Full Text] [Related]
15. Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndrome.
Jotterand Bellomo M; Parlier V; Mühlematter D; Grob JP; Beris P
Cancer Genet Cytogenet; 1992 Apr; 59(2):138-60. PubMed ID: 1581880
[TBL] [Abstract][Full Text] [Related]
16. Diabetes insipidus as first manifestation of acute myeloid leukaemia with EVI-1-positive, 3q21q26 syndrome and T cell-line antigen expression: what is the EVI-1 gene role?
Breccia M; Petti MC; Ottaviani E; Mancini M; D'Elia GM; Mecarocci S; Alimena G
Br J Haematol; 2002 Aug; 118(2):438-41. PubMed ID: 12139729
[TBL] [Abstract][Full Text] [Related]
17. Increased Evi-1 expression is frequently observed in blastic crisis of chronic myelocytic leukemia.
Ogawa S; Kurokawa M; Tanaka T; Tanaka K; Hangaishi A; Mitani K; Kamada N; Yazaki Y; Hirai H
Leukemia; 1996 May; 10(5):788-94. PubMed ID: 8656673
[TBL] [Abstract][Full Text] [Related]
18. Low expression of MDS1-EVI1-like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia.
Barjesteh van Waalwijk van Doorn-Khosrovani S; Erpelinck C; Löwenberg B; Delwel R
Exp Hematol; 2003 Nov; 31(11):1066-72. PubMed ID: 14585371
[TBL] [Abstract][Full Text] [Related]
19. Concurrent acute myeloid leukemia with inv(16)(p13.1q22) and chronic lymphocytic leukemia: molecular evidence of two separate diseases.
Lu CM; Murata-Collins JL; Wang E; Siddiqi I; Lawrence H
Am J Hematol; 2006 Dec; 81(12):963-8. PubMed ID: 16917916
[TBL] [Abstract][Full Text] [Related]
20. The New Clinicopathologic and Molecular Findings in Myeloid Neoplasms With inv(3)(q21q26)/t(3;3)(q21;q26.2).
Wang HY; Rashidi HH
Arch Pathol Lab Med; 2016 Dec; 140(12):1404-1410. PubMed ID: 27628325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
